Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Wutai Pharmaceutical is a comprehensive pharmaceutical manufacturer headquartered in Meihekou City, Jilin Province, China. Established in 1998, the company specializes in the production of chemical pharmaceuticals and Traditional Chinese Medicine (TCM) across multiple dosage forms, including powder injections, small-volume injections, tablets, and capsules. Its product portfolio primarily targets cardiovascular and cerebrovascular diseases, as well as bacterial and viral infections. Jilin Wutai operates modern, GMP-certified manufacturing facilities and maintains a significant presence in the domestic Chinese healthcare market. The company is recognized for its integration of traditional herbal medicine with modern pharmaceutical manufacturing standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Wuh Tai Pharmaceutical.